Both in Pharmaceuticals
Heron Therapeutics vs Boundless Bio
Over the past year HRTX returned −75.9% and BOLD returned +113.3%; their daily moves had a correlation of 0.03.
HRTX −75.9% BOLD +113.3%Growth of $1, one year, split-adjusted
| Metric | HRTX | BOLD |
|---|---|---|
| Price | $0.3060 | $2.56 |
| Market cap | $58.1M | $58.2M |
| Today | +4.87% | −1.92% |
| 1 month | −6.3% | −9.5% |
| 6 months | −59.0% | +135.9% |
| Year to date | −76.5% | +113.3% |
| 1 year | −74.7% | +124.6% |
| Revenue growth (YoY) | +1.3% | — |
| Gross margin | 69.3% | — |
| Net margin | −14.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | — |
| Net cash | -$100.0M | $72.6M |
| Dividend yield | — | — |
| Volatility (60d) | 97.3% | 31.0% |
| Short % of float | 30.3% | 6.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).